The future of inhalation therapy in chronic obstructive pulmonary disease
The inhaled route is critical for the administration of drugs to treat patients suffering from COPD, but there is still an unmet need for new and innovative inhalers to address some limitations of existing products that do not make them suitable for many COPD patients. The treatment of COPD, current...
Saved in:
Main Authors: | Mario Cazzola (Author), Josuel Ora (Author), Luigino Calzetta (Author), Paola Rogliani (Author), Maria Gabriella Matera (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
by: Mario Cazzola, et al.
Published: (2023) -
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
by: Ora J, et al.
Published: (2020) -
Drug interaction and chronic obstructive respiratory disorders
by: Paola Rogliani, et al.
Published: (2021) -
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
by: Cazzola M, et al.
Published: (2020) -
The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement
by: Luigino Calzetta, et al.
Published: (2024)